Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AzentaAZTA -2.34%70 EV-to-FCF is 29.52 as of Jul. 14, 2026, which is 2% below its 10-year median of 30.26. GuruFocus rates AZTA with a GF Score™ of 70/100 and a GF Value™ of $63.42 (Possible Value Trap). The stock has 2 warning signs investors should review. Among 414 Medical Devices & Instruments companies, Azenta ranks worse than 61.59% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Azenta's Enterprise Value is $847.8 Mil.
Azenta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $28.7 Mil. Therefore, Azenta's EV-to-FCF for today is 29.52.
The historical rank and industry rank for Azenta's EV-to-FCF or its related term are showing as below:
AZTA'
s EV-to-FCF Range Over the Past 10 Years
Min: -2619.22 Med: 30.26 Max: 633.02
Current: 29.52
During the past 13 years, the highest EV-to-FCF of Azenta was 633.02. The lowest was -2619.22. And the median was 30.26.
AZTA's EV-to-FCF is ranked worse than 61.59% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 23.445
vs AZTA: 29.52
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-14), Azenta's stock price is $25.44.
Azenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.960. Therefore, Azenta's PE Ratio (TTM) for today is At Loss.
Azenta (NAS:AZTA) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Azenta's share price for today is $25.44.
Azenta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.960.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Azenta EV-to-FCF Related Terms
Azenta EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Azenta's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Azenta's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Azenta EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Azenta's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Azenta's EV-to-FCF falls into.
Azenta's current Enterprise Value is $847.8 Mil.
Azenta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $28.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Azenta (AZTA) has a EV-to-FCF of 29.52 as of Jul. 14, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Azenta and its competitors. This is near median its historical median of 30.26. According to the industry distribution chart, Azenta ranks #255 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 61.6%.
Is Azenta's EV-to-FCF too high?
Azenta's current EV-to-FCF of 29.52 is near median its 10-year median of 30.26. The Medical Devices & Instruments industry median EV-to-FCF is 23.45. Azenta's value of 29.52 is 25.9% above this industry median. Based on the distribution chart, Azenta ranks #255 out of 414 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Azenta has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Azenta's EV-to-FCF compare to BLFS and STAA?
According to the Medical Devices & Instruments industry distribution chart, Azenta ranks #255 out of 414 companies for EV-to-FCF. This places Azenta in the lower half of its industry. The industry median EV-to-FCF is 23.45. Azenta's value of 29.52 is 25.9% above this benchmark. While the company's 10-year median is 30.26 vs. the industry median of 23.45, Azenta has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.45, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Azenta's current EV-to-FCF of 29.52 is 25.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Azenta and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Azenta's current EV-to-FCF is 29.52, which is near median its own 10-year median of 30.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Azenta stock overvalued right now?
Based on GuruFocus' analysis, Azenta (AZTA) is currently considered Possible Value Trap. The stock's GF Value™ is $63.42, compared to a current price of $25.44 — trading 59.9% below its estimated fair value. The current EV-to-FCF is 29.52, which is near median its 10-year median of 30.26 and 25.9% above the Medical Devices & Instruments industry median of 23.45. Azenta's overall GF Score™ is 70/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Azenta (AZTA), the current EV-to-FCF is 29.52 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Azenta (AZTA) Overvalued in 2026?
Based on GuruFocus' analysis, Azenta stock appears to be undervalued.
The current stock price of $25.44 is trading 59.9% below its estimated GF Value™ of $63.42.
GuruFocus considers Azenta to be Possible Value Trap.
Key valuation signals for AZTA:
EV-to-FCF: 29.52 (near median its 10-year median of 30.26)
GF Value™: $63.42 vs. price of $25.44 (59.9% below fair value)
Industry Position: 25.9% above the Medical Devices & Instruments median (#255 of 414)
No single metric tells the full story. See the AZTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.
70GF Score
Get the complete analysis for AZTA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AZTA has been successfully added to your 
